AVEO Pharmaceuticals, Inc. – Trademark Portfolio
Entity Type: 03
AVEO Pharmaceuticals, Inc. holds 33 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 26 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include AVEO, FOTIVDA, AVEO ONCOLOGY, and FOTIVDA (TIVOZANIB ). The owner is based in Cambridge, MA.
75 Sidney Street
Cambridge, MA 02139
Showing of trademarks Trademarks
Trademark Classifications
AVEO Pharmaceuticals, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does AVEO Pharmaceuticals, Inc. have?
AVEO Pharmaceuticals, Inc. has 33 U.S. trademarks filed with the USPTO. Of these, 6 registered, 19 abandoned, 8 cancelled.
What trademark classes does AVEO Pharmaceuticals, Inc. file in?
AVEO Pharmaceuticals, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are AVEO Pharmaceuticals, Inc.'s most well-known trademarks?
AVEO Pharmaceuticals, Inc.'s registered trademark portfolio includes well-known marks such as AVEO, FOTIVDA, AVEO ONCOLOGY, and FOTIVDA (TIVOZANIB ). These are among 6 currently registered trademarks in the portfolio.
What is AVEO Pharmaceuticals, Inc.'s trademark registration success rate?
AVEO Pharmaceuticals, Inc. has a 18% trademark registration rate, with 6 out of 33 resolved applications resulting in successful registration. Currently, 0 applications are pending review.